140 related articles for article (PubMed ID: 6277983)
1. Discrepancy between thyroid-stimulating and thyrotropin-binding inhibitory activities of Graves' immunoglobulin Gs assessed in the mouse.
Shishiba Y; Ozawa Y; Ohtsuki N; Shimizu T
J Clin Endocrinol Metab; 1982 Apr; 54(4):858-62. PubMed ID: 6277983
[TBL] [Abstract][Full Text] [Related]
2. Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves' disease.
Orgiazzi J; Williams DE; Chopra IJ; Solomon DH
J Clin Endocrinol Metab; 1976 Feb; 42(2):341-54. PubMed ID: 946604
[TBL] [Abstract][Full Text] [Related]
3. Extracts and auto-oxidized constituents of certain plants inhibit the receptor-binding and the biological activity of Graves' immunoglobulins.
Auf'mkolk M; Ingbar JC; Kubota K; Amir SM; Ingbar SH
Endocrinology; 1985 May; 116(5):1687-93. PubMed ID: 2985357
[TBL] [Abstract][Full Text] [Related]
4. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators.
Ealey PA; Valente WA; Ekins RP; Kohn LD; Marshall NJ
Endocrinology; 1985 Jan; 116(1):124-31. PubMed ID: 2856871
[TBL] [Abstract][Full Text] [Related]
5. [Thyroid stimulators other than TSH. Classification. Immunoglobulins of Basedow's disease: history, methodology, nomenclature].
Orgiazzi J; Madec AM
Ann Endocrinol (Paris); 1982 Dec; 43(6):509-19. PubMed ID: 6134492
[TBL] [Abstract][Full Text] [Related]
6. Interaction of the mouse thyrotrophin receptor with thyrotrophin binding inhibitor immunoglobulins.
Luttrell BM
J Endocrinol; 1983 Mar; 96(3):481-8. PubMed ID: 6131925
[TBL] [Abstract][Full Text] [Related]
7. Thyrotropin binding and long acting thyroid stimulator absorbing activities in subcellular fractions from isolated thyroid cells and thyroid homogenates.
Mehdi SQ; Badger J; Kriss JP
Endocrinology; 1977 Jul; 101(1):59-65. PubMed ID: 193685
[TBL] [Abstract][Full Text] [Related]
8. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
[TBL] [Abstract][Full Text] [Related]
9. IgG thyrotrophin receptor antibody activity in Graves' disease; a study of TSH agonist and antagonist activities by isoelectric focusing.
Creagh FM; Howells RD; Williams S; Didcote S; Hashim FA; Petersen VB; Rees Smith B
Clin Endocrinol (Oxf); 1986 Jan; 24(1):79-88. PubMed ID: 3011318
[TBL] [Abstract][Full Text] [Related]
10. Detection and measurement of fat cell-binding immunoglobulins: a new method applicable to the diagnosis and study of Graves' disease.
Shinozawa T; Villadolid MC; Ingbar SH
J Clin Endocrinol Metab; 1986 Jan; 62(1):1-9. PubMed ID: 2999173
[TBL] [Abstract][Full Text] [Related]
11. Changes in thyroid-stimulating immunoglobulins during antithyroid therapy.
Fenzi G; Hashizume K; Roudebush CP; DeGroot LJ
J Clin Endocrinol Metab; 1979 Apr; 48(4):572-6. PubMed ID: 581875
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to the human thyrotropin receptor are not species specific.
Davies TF
J Clin Endocrinol Metab; 1981 Mar; 52(3):426-30. PubMed ID: 6257747
[TBL] [Abstract][Full Text] [Related]
13. Comparison of LATS activity and TSH receptor antibody in Graves' disease.
Kajita Y; Nakajima Y; Ishida M; Ura Y; Ochi Y; Miyazaki T; Hachiya T; Ijichi H
Endocrinol Jpn; 1984 Jun; 31(3):369-74. PubMed ID: 6094169
[TBL] [Abstract][Full Text] [Related]
14. Soluble ecto-domain mutant of thyrotropin (TSH) receptor incapable of binding TSH neutralizes the action of thyroid-stimulating antibodies from Graves' patients.
Osuga Y; Liang SG; Dallas JS; Wang C; Hsueh AJ
Endocrinology; 1998 Feb; 139(2):671-6. PubMed ID: 9449640
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of TSH binding to chicken thyroid by some cases of LATS (long acting thyroid stimulator).
Nakajima Y; Ishida M; Kajita Y; Ura Y; Ochi Y; Miyazaki T; Hachiya T; Ijichi H
Endocrinol Jpn; 1986 Jun; 33(3):375-83. PubMed ID: 3019653
[TBL] [Abstract][Full Text] [Related]
16. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera.
Rotella CM; Zonefrati R; Toccafondi R; Valente WA; Kohn LD
J Clin Endocrinol Metab; 1986 Feb; 62(2):357-67. PubMed ID: 2416769
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of the binding of Graves' immunoglobulins by the patients own and other thyroid membranes.
Gossage AA; Byfield PG; Copping S; Himsworth RL
Clin Endocrinol (Oxf); 1981 Mar; 14(3):301-10. PubMed ID: 6894892
[TBL] [Abstract][Full Text] [Related]
18. Graves' IgG stimulation of continuously cultured rat thyroid cells: a sensitive and potentially useful clinical assay.
Vitti P; Valente WA; Ambesi-Impiombato FS; Fenzi GF; Pinchera A; Kohn LD
J Endocrinol Invest; 1982; 5(3):179-82. PubMed ID: 6286749
[TBL] [Abstract][Full Text] [Related]
19. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
Heyma P; Harrison LC
J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
[TBL] [Abstract][Full Text] [Related]
20. Clinical applications of assays for thyrotropin-receptor antibodies in Graves' disease.
Ginsberg J; von Westarp C
CMAJ; 1986 May; 134(10):1141-7. PubMed ID: 2421862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
